CryoPort Inc (CYRX)

[hyperopia]

I saw that headline earlier and it sounded like Cryoport rallied because Palynziq just received FDA approval, but it was just click bait. Unfortunately, Cryoport doesn’t support this treatment. Dr. Tran was recapping a number of stocks that BioSci Capital Partners covers but had nothing new on Cryoport, and was just promoting his subscription service which has an in-depth report on Cryoport. Did you see the comment Larry Smith made on the article? (I’ll give him a deserving plug)

Smith On Stocks, Contributor
Cryoport has been and remains one of my strongest recommendations. It may be the best way to invest in regnerative medicine that is based on living cells, arguably the most exciting new technology in biopharma. For an in-depth report on the company, see my initiation report written on April 12, 2017. The stock has quintupled since my intial recommendation. The link is smithonstocks.com/...
I look forward to the next quintuple although it is likely to take more than one year. My latest update on the company was on May 16, 2018. The link is smithonstocks.com/...

Ha ha. Yeah Larry it was a great pick, but I agree that it may take longer than a year to quintuple again. (but I hope it doesn’t)